The rapid advancement of molecular diagnostics necessitates portable, reliable, and highly sensitive testing platforms. Traditional diagnostic workflows often require multiple, separate laboratory components—including cell culture incubators, complex purification columns, and dedicated readers—making them unsuitable for decentralized Point-of-Care (PoC) settings. The development of integrated bioreactor-purification skids addresses this critical bottleneck by consolidating these sequential processes into a single, user-friendly, and robust cartridge system.
Problem Statement
Current PoC diagnostic limitations stem primarily from the need for complex sample preparation and analyte concentration. Biological samples (e.g., blood, saliva) contain high levels of inhibitors and require controlled biological reactions (e.g., cell culture, enzymatic amplification) before target detection. Separating the bioreaction phase from the purification phase introduces variability, increases reagent consumption, and necessitates specialized infrastructure. The core challenge is achieving laboratory-grade purity and sensitivity in a microfluidic, field-deployable format.
Integrated Mechanism
An integrated bioreactor-purification skid is a modular, closed-loop system designed to execute sample processing, biological amplification, and purification sequentially within a single disposable cartridge. This process involves three critical stages:
- Bioreaction Module: The process initiates in the bioreactor module, which is a microfluidic chamber designed for controlled environmental conditions. For pathogen detection, this module may house immobilized cells or enzymatic substrates to facilitate sample enrichment or amplification (e.g., isothermal amplification). Precise control over temperature, pH, and flow rate is maintained via integrated micro-pumps and thermal elements.
- Sample Conditioning and Purification: Following the bioreaction, the sample stream enters the purification module. This module employs advanced separation techniques, most commonly micro-affinity chromatography or solid-phase extraction (SPE) cartridges. The mechanism relies on selective binding: the target analyte is captured by immobilized ligands (e.g., antibodies, aptamers) within the matrix. Non-target contaminants, inhibitors, and excess reagents are washed away using controlled buffer flows.
- Elution and Detection: The purified target analyte is then released, or